Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Tuesday, May 20, 2025
SV Health’s $269 Million Fund Raise
Monday, May 19, 2025
CellCentric’s $120 Million Series C…More
Persist AI’s $12 Million Series A
Thursday, May 15, 2025
Pathos’s $365 Million Series D
Alpheus’s $52 Million Series B
Atara’s $16 Million Public Offering
Aura’s $12 Million Public Offering
Silo’s $2 Million Public Offering
Wednesday, May 14, 2025
Therini’s $39 Million Series A
Tuesday, May 13, 2025
Axsome’s$570 Million Debt Financing
Azafaros’s $147 Million Series B
Altimmune’s $100 Million Debt Financing
Stylus’s $85 Million Series A…More
Remedy Plan’s $18 Million Venture Financing
Monday, May 12, 2025
Friday, May 9, 2025
Sirius’s $50 Million Series B2
Apimeds’s $3 Million Public Offering
Thursday, May 8, 2025
HAYA’s $65 Million Series A…More
Wednesday, May 7, 2025
Immunewalk’s $7 Million Seed Round
Tuesday, May 6, 2025
NewLimit’s $130 Million Series B
Nuevocor’s $45 Million Series B
Paradigm’s $12 Million Venture Financing
Khondrion’s $6 Million Debt Financing
Pasithea’s $5 Million Public Offering
SOLVE’s $3 Million Equity Investment
Kane’s $1 Million Private Placement
Monday, May 5, 2025
Deerfield’s $600 Million Fund Raise
Can-Fite’s $175 Million Fund Raise
Friday, May 2, 2025
Stately’s $12 Million Seed Round
Sponsors
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck